GENEVA, July 9 -- NINGXIA EPPEN BIOTECH CO., LTD filed a patent application (CN2025/144140) for “USE OF NCGL0762 PROTEIN AND MUTANT THEREOF IN PRODUCTION OF L-ISOLEUCINE”. With publication no. WO/2026/145083, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 14/34
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....